Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Double laparotomy wound recurrence of endometrial carcinoma
1Department of Obstetrics and Gynecology, Department of Pathological Anatomy, "L. Armanni" Second University of Naples (SUN), Naples, Italy
*Corresponding Author(s): G.C. Balbi E-mail:
Introduction: Abdominal scar recurrence of endometrial carcinoma after abdominal total hysterectomy is very rare. We report a case of a 65-year-old woman who had two recurrences in the abdominal incisional scar after total hysterectomy.
Case report: A 65-year-old woman underwent total hysterectomy with bilateral salpingo-oophorectomy and pelvic lymphadenectomy because of well-differentiated endometrial adenocarcinoma (Stage IIB). Thus, the patient was treated by external beam radiotherapy. She developed two recurrences in the abdominal incisional scar two and three years after total hysterectomy, respectively. Surgery plus chemotherapy and surgery plus hormonal therapy were used for treatment of the first and second scar recurrence, respectively.
Conclusions: It is a very intriguing and controversial biologic question how neoplastic cells can implant and grow in an abdominal scar without other concomitant metastases. We report a review of the literature and the possible mechanism of recurrences in laparotomy wounds.
Endometrial cancer; Recurrence; Survival of recurring patients
G.C. Balbi,A. Cardone,A. Monteverde,M. Passaro,L. Montone,R. Rossiello,S. Visconti,M. Battisti,E. Cassese,I. Landino. Double laparotomy wound recurrence of endometrial carcinoma. European Journal of Gynaecological Oncology. 2006. 27(3);307-309.
[1] Wahlgvist L.: "Resection of the abdominal wall in metastasis from cancer of bladder, kidney or colon". Eur. Ural., 1977, 3, 26.
[2] Bedwinek J., Galakotos A. et al.: "Stage I grade III, adenocarc1-noma of the endometrium treated with surgery and irradiation". Cancer, 1984, 54, 40.
[3] Chambers S.K., Kapp D.S. et al.: "Prognostic factors and sites of failure in FIGO stage I, grade III, endometrial carcinoma". Gynecol. Oneal., 1987, 27, 180.
[4] Curtis M.G., Hopkins M.P. et al.: "Wound seeding associated with endometrial cancer". Gynecol. Oncol., 1994, 52, 413.
[5] Espinos J., Garcia-Patos V. et al.: "Early skin metastasis of endometrial carcinoma: case repost and review of literature" Cutis, 1993, 52, 109.
[6] Khalil Am., Chammes M.F. et al.: "Case report; endometrial cancer implanting in the laparotomy scar". Eur. J. Gynecol Oncol., 1998, 19, 408.
[7] Kotwall C.A., Kirkbride P. et al.: "Endometrial cancer and abdominal wound recurrence". Gynecol Oncol., 1994, 53, 357.
[8] Joshi S.C., Sharma D.N. et al.: "Endometrial carcinoma with recurrence in the incisional scar: A case report". Int. J. Gynecol. Cancer, 2003, 13, 901.
[9] Lorenz U., Gassel A.M. et al.: "Endometrial carcmoma recurrence in an abdominal scar 14 years after total hysterectomy". Gynecol. Oncol., 2004, 95, 393.
[10] Macias V., Baiotto B. et al.: "Laparotomy wound recurrence of endometrial cancer". Gynecol. Oncol., 2003, 91, 429.
[11] Muntz H.G., Goff B.A. et al.: "Port-site recurrence after laparoscopic surgery for endometrial carcinoma". Obstet. Gynecol., 1999, 93, 807.
[12] Ramirez P.T., Frumovitz M. et al.: "Laparoscopic port-site metastases in patients with gynaecological malignancies". Int. J Gynecol. Cancer, 2004, 14, 1070.
[13] Chapman G.W., Fabacher P.: "lncisional recurrence of endometrial carcinoma". J. Nat. Med. Assoc., 1988, 80, 359.
[14] American Cancer Society (ACS): Cancer facts and figures Atlanta, 1998. G.A.: ACS, 1998.
[15] Sonoda Y.: "Optimal therapy and management of endometrial cancer". Expert Rev. Anticancer Ther, 2003, 3, 37.
[16] Sutton G.P.: "The significance of positive peritoneal cytology in endometrial cancer". Oncology, 1990, 4, 23.
[17] Ardies C.M.: "Inflammation as cause for scar cancers of the lung" Integr. Cancer Ther., 2003, 2, 238.
[18] DerHagopian R.P., Sugerbaker E.V.: "Inflammatory oncotaxis" JAMA, 1978, 240, 374.
[19] Morrow C., Bundy B. et al.: "Relationships between surgicalpathologic risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study". Gynecol. Oncol., 1991, 40, 55.
Top